GALDIERO, STEFANIA
 Distribuzione geografica
Continente #
AS - Asia 9.486
NA - Nord America 9.038
EU - Europa 7.874
SA - Sud America 1.225
AF - Africa 262
OC - Oceania 20
Continente sconosciuto - Info sul continente non disponibili 14
Totale 27.919
Nazione #
US - Stati Uniti d'America 8.672
SG - Singapore 4.302
RU - Federazione Russa 2.915
IT - Italia 2.381
CN - Cina 1.748
VN - Vietnam 1.738
BR - Brasile 954
HK - Hong Kong 712
DE - Germania 504
FR - Francia 385
FI - Finlandia 324
IE - Irlanda 282
NL - Olanda 253
UA - Ucraina 239
CA - Canada 193
GB - Regno Unito 171
IN - India 168
JP - Giappone 166
SE - Svezia 157
BD - Bangladesh 130
AR - Argentina 109
MX - Messico 107
CI - Costa d'Avorio 80
PL - Polonia 66
KR - Corea 64
ZA - Sudafrica 64
IQ - Iraq 58
EC - Ecuador 47
PH - Filippine 47
ES - Italia 46
ID - Indonesia 42
TH - Thailandia 42
PK - Pakistan 40
TR - Turchia 39
IR - Iran 31
AT - Austria 30
TW - Taiwan 23
CL - Cile 22
DZ - Algeria 21
PT - Portogallo 20
PY - Paraguay 20
MA - Marocco 19
PE - Perù 19
CO - Colombia 18
VE - Venezuela 18
AE - Emirati Arabi Uniti 14
AU - Australia 13
CH - Svizzera 13
EG - Egitto 13
JO - Giordania 13
UZ - Uzbekistan 12
MY - Malesia 11
NP - Nepal 11
SA - Arabia Saudita 11
A1 - Anonimo 10
CR - Costa Rica 10
TN - Tunisia 10
CZ - Repubblica Ceca 9
KE - Kenya 9
AZ - Azerbaigian 8
BO - Bolivia 8
BY - Bielorussia 8
LT - Lituania 8
PS - Palestinian Territory 8
BE - Belgio 7
IL - Israele 7
JM - Giamaica 7
KZ - Kazakistan 7
LB - Libano 7
RO - Romania 7
SY - Repubblica araba siriana 7
TT - Trinidad e Tobago 7
UY - Uruguay 7
AL - Albania 6
ET - Etiopia 6
GT - Guatemala 6
HN - Honduras 6
HR - Croazia 6
SN - Senegal 6
NZ - Nuova Zelanda 5
BS - Bahamas 4
GR - Grecia 4
MD - Moldavia 4
MN - Mongolia 4
NG - Nigeria 4
OM - Oman 4
PA - Panama 4
SV - El Salvador 4
BW - Botswana 3
DK - Danimarca 3
GE - Georgia 3
LV - Lettonia 3
MK - Macedonia 3
NI - Nicaragua 3
NO - Norvegia 3
PR - Porto Rico 3
SD - Sudan 3
XK - ???statistics.table.value.countryCode.XK??? 3
AF - Afghanistan, Repubblica islamica di 2
BF - Burkina Faso 2
Totale 27.855
Città #
Singapore 1.972
San Jose 1.248
Chandler 828
Moscow 685
Hong Kong 683
Ashburn 606
Beijing 505
Ho Chi Minh City 481
Hanoi 409
Santa Clara 400
Naples 350
Napoli 317
Millbury 285
The Dalles 267
Los Angeles 237
Lauterbourg 226
Jacksonville 206
Amsterdam 200
Princeton 197
Nanjing 185
Hefei 183
Tokyo 146
Dallas 137
New York 126
Boston 124
Council Bluffs 113
Buffalo 112
Munich 110
Wilmington 107
Woodbridge 106
Des Moines 105
São Paulo 100
Rome 84
Redondo Beach 80
Ottawa 79
Da Nang 75
Milan 73
Helsinki 67
Haiphong 65
Frankfurt am Main 59
Houston 58
Dong Ket 54
Orem 49
Lawrence 48
Warsaw 48
Seattle 46
Nanchang 45
Turku 45
Montreal 44
Brooklyn 42
Kronberg 40
Denver 39
London 39
Shenyang 38
Atlanta 37
Chennai 35
Chicago 35
Redwood City 35
Tianjin 35
Phoenix 34
Hebei 32
Mexico City 32
San Francisco 32
Boardman 31
Seoul 31
Biên Hòa 30
Johannesburg 30
Rio de Janeiro 30
Dublin 28
Norwalk 27
Falkenstein 25
Hải Dương 25
Stockholm 25
Toronto 24
Turin 24
Pune 23
Belo Horizonte 22
Brasília 22
Ninh Bình 22
Bangkok 21
Bari 21
Lappeenranta 21
Nuremberg 21
Charlotte 20
Dresden 19
Can Tho 18
Jiaxing 18
Cagliari 17
Shanghai 17
Ankara 16
Curitiba 16
Ribeirão Preto 16
Baghdad 15
Guayaquil 15
Lima 15
Mumbai 15
Poplar 15
Thái Nguyên 15
Bến Tre 14
Changsha 14
Totale 14.058
Nome #
Meccanismi innovativi di trasporto attraverso la barriera ematoencefalica: peptidi e nanoparticelle 985
L'ormone alfa-melanocitario (alfa-MSH) e le beta defensine umane nelle infezioni da multi-drug resistant Staphylococcus aureus 261
A cell-penetrating peptide as a tool for delivery to blood brain barrier (BBB) 206
A powerful in silico approach allowed the identification of a new antimicrobial peptide from the third domain of life 182
PACAP-LOADED LIPOSOME DELIVERY ACROSS THE BBB: A LIGHT-SHEET MICROSCOPY STUDY 167
Neuroprotective Effects of gH625-lipoPACAP in an In Vitro Fluid Dynamic Model of Parkinson’s Disease 161
Myxinidin-Derived Peptide against Biofilms Caused by Cystic Fibrosis Emerging Pathogens 160
Structural studies of proteins in the intracellular environment:design and characterization of suitable cell systems 159
Unveiling the mechanism of action of acylated temporin L analogues against multidrug-resistant Candida albicans 156
OctoPartenopin: Identification and Preliminary Characterization of a Novel Antimicrobial Peptide from the Suckers of Octopus vulgaris 156
Effect of lipid composition and peptide sequence on the interaction between myxinidin and model membranes 156
Silver Nanoparticles as Potential Antibacterial Agents 155
Competitiveness during Dual-Species Biofilm Formation of Fusarium oxysporum and Candida albicans and a Novel Treatment Strategy 155
Viral fusion peptides induce several signal transduction pathways activation that are essential for IL-10 and -interferon production 154
The membranotropic peptide gh625 to combat mixed candida albicans/klebsiella pneumoniae biofilm: Correlation between in vitro anti-biofilm activity and in vivo antimicrobial protection 153
Quantitative and qualitative effect of gH625 on the nanoliposome-mediated delivery of mitoxantrone anticancer drug to HeLa cells 152
Enhanced uptake of gH625 by blood brain barrier compared to liver in vivo: characterization of the mechanism by an in vitro model and implications for delivery 152
The identification and characterization of a novel CAMP from Stf76, a Sulfolobus islandicus plasmid-virus pSSVx transcription factor 151
Antimicrobial peptides at work: interaction of myxinidin and its mutant WMR with lipid bilayers mimicking the P. aeruginosa and E. coli membranes 151
Impact of the peptide wmr-k on dual-species biofilm candida albicans/klebsiella pneumoniae and on the untargeted metabolomic profile 151
The identification of a novel Sulfolobus islandicus CAMP-like peptide points to archaeal microorganisms as cell factories for the production of antimicrobial molecules 151
Antifungal and Antibiofilm Activity of Cyclic Temporin L Peptide Analogues against Albicans and Non-Albicans Candida Species 150
Liposomal doxorubicin doubly functionalized with CCK8 and R8 peptide sequences for selective intracellular drug delivery 150
Analysis of a Herpes virus type 1 glycoprotein H functional domain. 149
A peptide derived from Herpes Simplex Virus type 1 glycoprotein H: membrane translocation and applications to the delivery of quantum dots 149
A boost to the antiviral activity: Cholesterol tagged peptides derived from glycoprotein B of Herpes Simplex virus type I 148
gH625-liposomes deliver PACAP through a dynamic in vitro model of the blood-brain barrier 147
Modelling of protein P2 from Haemophilus influenzae: the role of surface exposed loops on MEK1/MEK2/MAPK cascade activation 147
Peptides containing membrane-interacting motifs inhibit herpes simplex virus type 1 infectivity 147
Role of membranotropic sequences from herpes simplex virus type I glycoproteins B and H in the fusion process. 145
Multigenerational effects and DNA alterations of QDs-Indolicidin on Daphnia magna. 145
MicroRNA 199b-5p delivery through stable nucleic acid lipid particles (SNALPs) in tumorigenic cell lines 144
WMR Peptide as Antifungal and Antibiofilm against Albicans and Non-Albicans Candida Species: Shreds of Evidence on the Mechanism of Action 144
Properties of a membrane interacting region of herpes simplex virus type 1 glycoprotein H 143
Ecotoxicity evaluation of pristine and indolicidin-coated silver nanoparticles in aquatic and terrestrial ecosystem 143
Characterisation of fusogenic domains in glycoprotein B from Herpes virus type I 142
Beta-defensins and analogs in Helicobacter pylori infections: mRNA expression levels, DNA methylation, and antibacterial activity 142
gH625 is a viral derived peptide for effective delivery of intrinsically disordered proteins. 141
Surface decoration with gH625-membranotropic peptides as a method to escape the endo-lysosomal compartment and reduce nanoparticle toxicity 141
Synthesis and immuno-characterization of branched polipeptide coniugate as vaccines for HSV-1 virus 140
Synthesis and immuno-characterization of HSV-1 peptides for a potential vaccine 140
Biophysical characterization and membrane interaction of the two fusion loops of glycoprotein B from herpes simplex type I virus. 140
HOST DEFENSE TEMPORIN 1 PEPTIDES AND THEIR POTENTIAL AS ANTIVIRAL AGENTS 140
Clickable functionalization of liposomes with gH625 peptide from Herpes simplex virus type I for intracellular delivery 139
Viral Peptide Targeted Delivery of Nano-Therapeutics 139
Biophysical characterization and membrane interaction of the two fusion loops of glycoprotein B from herpes simplex virus type I 139
An integrated study on antimicrobial activity and ecotoxicity of quantum dots and quantum dots coated with the antimicrobial peptide indolicidin 139
Metabolomic and oxidative effects of quantum dots-indolicidin on three generations of Daphnia magna 138
Synthetic Amphipathic β-Sheet Temporin-Derived Peptide with Dual Antibacterial and Anti-Inflammatory Activities 137
The Crystal Structure of Afc containing Peptides 137
“CpHV1 vaccines based on peptide conjugates: Synthesis and Characterization” 136
Cyclic beta defensisns analogs for the tratment of infections 136
Peptides to Overcome the Limitations of Current Anticancer and Antimicrobial Nanotherapies 135
Synthetic analogs of human beta-defensin having antimicrobial, antiviral and chemotactic activity 135
Microbe-host interactions: structure and role of Gram-negative bacterial porins. 135
Cyclic beta defensins analogs fot the treatment of infections 135
gH625-liposomes as tool for pituitary adenylate cyclase-activating polypeptide brain delivery 135
Enhancing the Potency of Antimicrobial Peptides through Molecular Engineering and Self-Assembly 134
Method for delivery of molecules into intracellular targets 134
Genotoxicity of gold nanoparticles functionalized with indolicidin towards Saccharomyces cerevisiae 134
Shuttle-Mediated Nanoparticle Delivery to the Blood–Brain Barrier 133
The Crystal Structure of a Dcp containing Peptide 132
12th Naples Workshop on bioactive peptides & 2nd Italy-Korea Symposium on antimicrobial Peptides 132
Engineering of Porin P2 loop 7 from Haemophilus influenzae: structural requirements for proinflammatory activity 132
Tuning Peptide-Based Nanofibers for Achieving Selective Doxorubicin Delivery in Triple-Negative Breast Cancer 131
Viral Peptide Targeted Delivery of Nano-Therapeutics 131
Exploring Fe(III) coordination and membrane interaction of a siderophore-peptide conjugate: Enhancing synergistically the antimicrobial activity 130
Synthesis, conformation, and bioactivity of novel analogues of the antiviral lipopeptide halovir A. 129
An ancestral host defence peptide within human β-defensin 3 recapitulates the antibacterial and antiviral activity of the full-length molecule 129
Tumor-activated prodrug (TAP) - conjugated nanoparticles with cleavable domains for safe doxorubicin delivery 128
Integrated analysis of the ecotoxicological and genotoxic effects of the antimicrobial peptide melittin on Daphnia magna and Pseudokirchneriella subcapitata 126
Eradication of Candida albicans persister cell biofilm by the membranotropic peptide gH625 126
The world of cell penetrating: The future of medical applications 126
First-in-Class Cyclic Temporin L Analogue: Design, Synthesis, and Antimicrobial Assessment 126
Nanocarriers Conjugated with Cell Penetrating Peptides: New Trojan Horses by Modern Ulysses 125
Peptide shuttles for intracellular delivery of CdSe Quantum Dots 124
β-barrel membrane bacterial proteins: structure, function, assembly and interaction with lipids 123
Protein P2 from Haemophilus Influenzae: the role of its surface exposed loops on the mitogen-activated protein kinase cascade 123
Pathophysiological changes of gram-negative bacterial infection can be reproduced by a synthetic peptide mimicking loop L7 sequence of Haemophilus influenzae porin 123
Mappa proteica indotta dall’attivazione da loop 7 della porina di Haemophilus influenzae in monociti umani di linea. 123
Membranotropic Peptide-Functionalized Poly(lactide)-graft-poly(ethylene glycol) Brush Copolymers for Intracellular Delivery 123
Host Defense Peptide-derived Privileged Scaffolds for Anti-infective Drug Discovery 123
Structural analysis membranotropic domains of Herpes simplex virus type I glycoprotein H 122
A new hope: Self-assembling peptides with antimicrobial activity 122
Engineering of janus-like dendrimers with peptides derived from glycoproteins of herpes simplex virus type 1: Toward a versatile and novel antiviral platform 122
Mapping key interactions in the dimerization process of HBHA from Mycobacterium tuberculosis, insights into bacterial agglutination. 121
Design and Validation of Nanofibers Made of Self-Assembled Peptides to Become Multifunctional Stimuli-Sensitive Nanovectors of Anticancer Drug Doxorubicin 120
A NEW STRATEGY TO DELIVER PACAP TO THE BRAIN 119
Studi di Relazione struttura funzione: le beta-defensine umane 118
Amino Acids, Peptides and Proteins: Volume 42 118
Fusogenic domains in herpes simplex virus type 1 glycoprotein H. 117
Daphnia magna and Xenopus laevis as in vivo models to probe toxicity and uptake of quantum dots functionalized with gH625 116
Efficiency of gold nanoparticles coated with the antimicrobial peptide indolicidin against biofilm formation and development of Candida spp. clinical isolates 116
Membrane Fusion and Fission: enveloped viruses 115
A single amino acid addition enhances the fusion promotion activity of a membranotropic region of HSV-1 glycoprotein H 115
Review of a viral peptide nanosystem for intracellular delivery 115
A novel system for delivery 115
Design and activity of a cyclic mini-β-defensin analog: a novel antimicrobial tool 115
A Trans-Kingdom Antimicrobial Peptide Targeting Cystic Fibrosis Pathogens 115
Marine antimicrobial peptides: Nature provides templates for the design of novel compounds against pathogenic bacteria 115
Totale 14.682
Categoria #
all - tutte 88.693
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 88.693


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.540 98 9 27 48 34 57 19 67 284 104 215 578
2022/20232.062 298 165 95 183 204 247 36 190 304 190 107 43
2023/20241.525 63 265 180 110 90 107 47 178 43 53 245 144
2024/20256.789 348 465 42 78 213 380 788 405 495 679 2.301 595
2025/202612.904 1.269 877 1.221 1.280 2.339 505 1.491 911 1.457 923 314 317
2026/2027122 122 0 0 0 0 0 0 0 0 0 0 0
Totale 28.462